AUROBINDO PHARMA LTD Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AUROBINDO PHARMA LTD, and what generic and branded alternatives to AUROBINDO PHARMA LTD drugs are available?
AUROBINDO PHARMA LTD has two hundred and eighteen approved drugs.
There are fifteen tentative approvals on AUROBINDO PHARMA LTD drugs.
Summary for AUROBINDO PHARMA LTD
| US Patents: | 0 |
| Tradenames: | 181 |
| Ingredients: | 174 |
| NDAs: | 218 |
| Drug Master File Entries: | 237 |
| Patent Litigation for AUROBINDO PHARMA LTD: | See patent lawsuits for AUROBINDO PHARMA LTD |
Drugs and US Patents for AUROBINDO PHARMA LTD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | LANSOPRAZOLE | lansoprazole | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 207167-002 | Mar 28, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aurobindo Pharma Ltd | NICOTINE POLACRILEX | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 215357-001 | May 13, 2022 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Aurobindo Pharma Ltd | ABACAVIR SULFATE | abacavir sulfate | TABLET;ORAL | 077844-001 | Dec 17, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aurobindo Pharma Ltd | APREMILAST | apremilast | TABLET;ORAL | 211716-001 | Jul 19, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
